Aardvark Therapeutics, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Aardvark Therapeutics, Inc. reported Cash And Cash Equivalents At Carrying Value of $47.05 million for the year ending 2025.

  • Aardvark Therapeutics, Inc. showed a decrease of -23.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Aardvark Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
  • XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Historical annual values: Fiscal year 2025: $47.05 million | Fiscal year 2024: $61.64 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: